Literature DB >> 11844204

Relationship between nuchal translucency at 11-14 weeks and nuchal fold at 20-24 weeks of gestation.

L J Salomon1, J P Bernard, P Taupin, C Benard, Y Ville.   

Abstract

OBJECTIVES: To examine the relationship between the measurement of nuchal translucency in the first trimester and nuchal fold in the second trimester in normal pregnancy.
METHODS: This was a prospective study of 592 singleton pregnancies. Fetal nuchal translucency was measured at 11-14 weeks of gestation and nuchal fold at 20-24 weeks of gestation. Linear regression models were used to assess the relationship between nuchal translucency and nuchal fold after adjustment for gestational age.
RESULTS: There was no significant association between nuchal translucency and nuchal fold thickness.
CONCLUSION: It is possible that measurement of nuchal translucency and nuchal fold may provide an independent contribution in screening for trisomy 21.

Mesh:

Year:  2001        PMID: 11844204     DOI: 10.1046/j.0960-7692.2001.00582.x

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  7 in total

Review 1.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 2.  First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 3.  Second trimester serum tests for Down's Syndrome screening.

Authors:  S Kate Alldred; Jonathan J Deeks; Boliang Guo; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

4.  Role of second-trimester genetic sonography after Down syndrome screening.

Authors:  Kjersti M Aagaard-Tillery; Fergal D Malone; David A Nyberg; T Flint Porter; Howard S Cuckle; Karin Fuchs; Lisa Sullivan; Christine H Comstock; George R Saade; Keith Eddleman; Susan Gross; Lorraine Dugoff; Sabrina D Craigo; Ilan E Timor-Tritsch; Stephen R Carr; Honor M Wolfe; Diana W Bianchi; Mary E D'Alton
Journal:  Obstet Gynecol       Date:  2009-12       Impact factor: 7.661

Review 5.  First trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-11-30

Review 6.  Urine tests for Down's syndrome screening.

Authors:  S Kate Alldred; Boliang Guo; Yemisi Takwoingi; Mary Pennant; Susanna Wisniewski; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10

7.  Reference values of nuchal fold thickness in an Iranian population sample.

Authors:  Kimia Kazemi; Atoosa Adibi; Silva Hovsepian
Journal:  J Res Med Sci       Date:  2018-10-26       Impact factor: 1.852

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.